Cubist Pharmaceuticals, Inc.
Cubist Pharmaceuticals, Inc. appears in FDA public data with 4 recalls — including 4 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0229-2015, Class I) was initiated on August 8, 2014.
Summary
- Total Recalls
- 4 (4 Class I)
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0229-2015 | Class I | CUBICIN (daptomycin for injection) 500 mg, For Intravenous Use Only, Rx Only, Single use Vial, Manu | August 8, 2014 |
| D-0001-2015 | Class I | CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharma | August 1, 2014 |
| D-1382-2014 | Class I | CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharma | April 17, 2014 |
| D-764-2014 | Class I | Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manu | August 29, 2013 |